title: Comparison of rapamycin, RS 61443, cyclosporine, and low-dose heparin as treatment for transplant vasculopathy in a rat model of chronic allograft rejection.
authors.affiliation: Surgical Research Laboratory, Harvard Medical School, Boston, Massachusetts.
authors.forename: C
authors.initials: C
authors.lastname: Schmid
authors.forename: U
authors.initials: U
authors.lastname: Heemann
authors.forename: H
authors.initials: H
authors.lastname: Azuma
authors.forename: N L
authors.initials: NL
authors.lastname: Tilney
mesh_terms: D000818:Animals; D016572:Cyclosporine / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D006084:Graft Rejection / Q000473:pathology / Q000517:prevention & control*; D006085:Graft Survival; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology*; D006493:Heparin / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D011090:Polyenes / Q000627:therapeutic use*; D051381:Rats; D011916:Rats, Inbred F344; D011917:Rats, Inbred Lew; D020123:Sirolimus; D014184:Transplantation, Homologous
chemical_list: D007166:Immunosuppressive Agents; D011090:Polyenes; D016572:Cyclosporine; D006493:Heparin; D020123:Sirolimus